Aqr Capital Management LLC Mirati Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $1.62 Million - $2.18 Million	-12,292 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $710,352 - $886,608	-4,933 Reduced 28.64%	12,292 $1.99 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $519,668 - $724,664	-3,270 Reduced 15.96%	17,225 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $1.26 Million - $1.86 Million	7,745 Added 60.75%	20,495 $4.5 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $392,219 - $579,256	-3,463 Reduced 21.36%	12,750 $2.12 Million
Q2 2020 Aug 17, 2020	BUY	$72.01 - $120.39 $71,505 - $119,547	993 Added 6.52%	16,213 $1.85 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $108,577 - $180,822	1,556 Added 11.39%	15,220 $1.17 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $122,061 - $222,283	1,725 Added 14.45%	13,664 $1.76 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $52,433 - $73,760	-673 Reduced 5.34%	11,939 $930,000
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $194,115 - $341,668	-3,263 Reduced 20.55%	12,612 $1.3 Million
Q1 2019 May 14, 2019	SELL	$43.65 - $78.95 $2.55 Million - $4.61 Million	-58,336 Reduced 78.61%	15,875 $1.16 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $422,688 - $626,502	-13,209 Reduced 15.11%	74,211 $3.15 Million
Q3 2018 Nov 15, 2018	BUY	$47.1 - $62.7 $1.62 Million - $2.16 Million	34,501 Added 65.2%	87,420 $4.12 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $1.38 Million - $2.77 Million	52,919 New	52,919 $2.61 Million

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.